Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.31 AUD | +1.55% | -4.38% | +55.95% |
Mar. 26 | Race Oncology Obtains Certificate of Analysis for RC220; Shares Up Almost 6% | MT |
Mar. 18 | Race Oncology Limited(ASX:RAC) dropped from S&P/ASX All Ordinaries Index | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Daniel Tillett
CEO | Chief Executive Officer | - | Nov. 21 |
Chief Tech/Sci/R&D Officer | - | 23-06-30 | |
Tim Hammond
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-22 |
Michael Kelso
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-30 |
Chief Tech/Sci/R&D Officer | - | 20-02-29 | |
Phillip Lynch
BRD | Director/Board Member | - | 20-05-31 |
Sophia Moscovis
PRN | Corporate Officer/Principal | - | - |
Borje Andersson
PRN | Corporate Officer/Principal | - | 20-01-31 |
Peter Webse
SEC | Corporate Secretary | 61 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Smith
BRD | Director/Board Member | 61 | 23-06-28 |
Borje Andersson
PRN | Corporate Officer/Principal | - | 20-01-31 |
Phillip Lynch
BRD | Director/Board Member | - | 20-05-31 |
Mary Harney
CHM | Chairman | - | 21-02-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 163,496,251 | 120,724,467 ( 73.84 %) | 0 | 73.84 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+55.95% | 142M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- RAC Stock
- Company Race Oncology Limited